Otonomy, Inc. Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference
9/29/2011 11:03:57 AM
More...
|
Otonomy, Inc. Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure
6/8/2011 7:43:17 AM
More...
|
Otonomy, Inc. Appoints Gerald Wroblewski as Chief Operations Officer
5/25/2011 9:39:05 AM
More...
|
Otonomy, Inc. Announces Positive Results from Phase 1b Study of OTO-104 in Meniere's Disease
4/28/2011 7:27:34 AM
More...
|
Otonomy, Inc.'s OTO-104 Demonstrates Hearing Loss Protection and Hearing Recovery in Preclinical Studies
2/22/2011 8:22:24 AM
More...
|
Otonomy, Inc. Adds Key Product and Industry Experience with Appointment of New Vice Presidents
2/3/2011 6:29:28 AM
More...
|
Otonomy, Inc. Appoints David A. Weber, Ph.D., Chief Executive Officer
12/8/2010 6:14:13 AM
More...
|
Otonomy, Inc. Closes $38.5 Million Series B Financing
8/30/2010 6:34:10 AM
More...
|
Otonomy, Inc. Closes $10 Million Series A Financing
6/11/2010 7:17:58 AM
More...
|
Otonomy, Inc. Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
2/17/2010 8:32:00 AM
More...
|
|